{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:27:56Z","timestamp":1793395676874,"version":"4.5.0"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51901160"],"award-info":[{"award-number":["51901160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ijbiomac.2023.126000","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T21:00:28Z","timestamp":1690837228000},"page":"126000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Cell membrane nanomaterials composed of phospholipids and glycoproteins for drug delivery in inflammatory bowel disease: A review"],"prefix":"10.1016","volume":"249","author":[{"given":"Pengyu","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinsi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.126000_bb0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41575-020-0331-7","article-title":"Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD","volume":"17","author":"Kudelka","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0010","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0015","first-page":"699","article-title":"Ulcerative colitis","volume":"87","author":"Adams","year":"2013","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0020","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn's disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0025","doi-asserted-by":"crossref","first-page":"xiii","DOI":"10.1016\/j.gtc.2017.06.001","article-title":"Crohn's disease: etiology, complications, assessment, therapy, and management","volume":"46","author":"Loftus","year":"2017","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0030","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.2147\/IJN.S210315","article-title":"Nanoparticle-mediated drug delivery systems for the treatment of IBD: current perspectives","volume":"14","author":"Yang","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/14712598.2019.1666101","article-title":"Modern use of 5-aminosalicylic acid compounds for ulcerative colitis","volume":"20","author":"Le Berre","year":"2020","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ecco-jcc\/jjx101","article-title":"European Crohn's and colitis organisation topical review on treatment withdrawal [\u2018exit strategies\u2019] in inflammatory bowel disease","volume":"12","author":"Doherty","year":"2018","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0045","doi-asserted-by":"crossref","first-page":"691480","DOI":"10.3389\/fimmu.2021.691480","article-title":"Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice","volume":"12","author":"Bruscoli","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0050","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3748\/wjg.v25.i9.1142","article-title":"Conventional therapy for moderate to severe inflammatory bowel disease: a systematic literature review","volume":"25","author":"Dami\u00e3o","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2023.126000_bb0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000341951","article-title":"First-line therapies in inflammatory bowel disease","volume":"86","author":"Girardin","year":"2012","journal-title":"Digestion."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/biomedicines10040749","article-title":"Is there a best first line biological\/small molecule in IBD: are we ready for sequencing?","volume":"10","author":"Hahn","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0065","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.3748\/wjg.v23.i27.4986","article-title":"Management of inflammatory bowel disease with Clostridium difficile infection","volume":"23","author":"D'Aoust","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0070","doi-asserted-by":"crossref","first-page":"13289","DOI":"10.1016\/S0021-9258(17)36831-X","article-title":"Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression","volume":"269","author":"Mukaida","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-med-042320-021020","article-title":"The gut microbiome and inflammatory bowel diseases","volume":"73","author":"Shan","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0080","doi-asserted-by":"crossref","first-page":"934695","DOI":"10.3389\/fimmu.2022.934695","article-title":"Akkermansia muciniphila and gut immune system: a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes","volume":"13","author":"Rodrigues","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0085","doi-asserted-by":"crossref","first-page":"622354","DOI":"10.3389\/fmicb.2020.622354","article-title":"Prevention and alleviation of dextran sulfate sodium salt-induced inflammatory bowel disease in mice with Bacillus subtilis-fermented milk via inhibition of the inflammatory responses and regulation of the intestinal Flora","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Microbiol. Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00535-021-01774-3","article-title":"Lactobacillus stress protein GroEL prevents colonic inflammation","volume":"56","author":"Dias","year":"2021","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0095","first-page":"4866","article-title":"Therapeutic potential and deleterious effect of glucocorticoids on azoxymethane\/dextran sulfate sodium-induced colorectal cancer in mice","volume":"11","author":"Pu","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0100","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151815","article-title":"Intestinal epithelial glucocorticoid receptor promotes chronic inflammation-associated colorectal cancer","volume":"6","author":"Tang","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.steroids.2018.10.008","article-title":"Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis","volume":"140","author":"Conklin","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0110","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1038\/s41467-019-13727-9","article-title":"Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment","volume":"10","author":"Cao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0115","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ecco-jcc\/jjv096","article-title":"Infliximab-related infusion reactions: systematic review","volume":"9","author":"Lichtenstein","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0120","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/1574884715666200714114044","article-title":"Corticosteroids in inflammatory bowel disease patients: a practical guide for physicians","volume":"16","author":"Di Paolo","year":"2021","journal-title":"Curr. Rev. Clin. Exp. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0125","first-page":"65","article-title":"Low bioavailability and traditional systemic steroids in IBD: can the former take over the latter?","volume":"22","author":"Fasci Spurio","year":"2013","journal-title":"J. Gastrointest. Liver Dis."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0130","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1038\/s41467-019-13727-9","article-title":"Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment","volume":"10","author":"Cao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0135","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.7150\/thno.38081","article-title":"Orally deliverable nanotherapeutics for the synergistic treatment of colitis-associated colorectal cancer","volume":"9","author":"Han","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2019.02.030","article-title":"Efficacy of budesonide-loaded mesoporous silica microparticles capped with a bulky azo derivative in rats with TNBS-induced colitis","volume":"561","author":"Ferri","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2018.12.074","article-title":"Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease","volume":"558","author":"Zeeshan","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.02.028","article-title":"Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment","volume":"345","author":"Wang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0155","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1021\/acs.molpharmaceut.8b00357","article-title":"Entrapping of nanoparticles in yeast cell wall microparticles for macrophage-targeted oral delivery of cabazitaxel","volume":"15","author":"Ren","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ymeth.2019.12.004","article-title":"Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications","volume":"177","author":"Choi","year":"2020","journal-title":"Methods"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0165","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s11095-022-03328-5","article-title":"Red blood cell inspired strategies for drug delivery: emerging concepts and new advances","volume":"39","author":"Zhang","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0170","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3390\/ijms23042223","article-title":"Cell membrane-cloaked nanotherapeutics for targeted drug delivery","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/nsr\/nwz037","article-title":"Cell membrane-covered nanoparticles as biomaterials","volume":"6","author":"Xuan","year":"2019","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0180","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.apsb.2022.02.023","article-title":"Cell membrane coated-nanoparticles for cancer immunotherapy","volume":"12","author":"Zeng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5217\/ir.2018.16.1.26","article-title":"Immunological pathogenesis of inflammatory bowel disease","volume":"16","author":"Lee","year":"2018","journal-title":"Intest. Res."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","article-title":"Environmental triggers in IBD: a review of progress and evidence","volume":"15","author":"Ananthakrishnan","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0195","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MIB.0000000000000236","article-title":"Cytokines, IBD, and colitis-associated cancer, inflammatory bowel diseases","volume":"21","author":"Francescone","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0200","first-page":"1163","article-title":"Genetics of inflammatory bowel diseases","volume":"149","author":"McGovern","year":"2015"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/nu11051033","article-title":"Implications of the westernized diet in the onset and progression of IBD","volume":"11","author":"Rizzello","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0210","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/gutjnl-2019-320065","article-title":"Big data in IBD: big progress for clinical practice","volume":"69","author":"Seyed Tabib","year":"2020","journal-title":"Gut."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0215","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0220","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/gut.2009.199679","article-title":"New IBD genetics: common pathways with other diseases","volume":"60","author":"Lees","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41467-020-20348-0","article-title":"NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn's disease","volume":"12","author":"Rochereau","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0230","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12958","article-title":"The roles and functions of paneth cells in Crohn's disease: a critical review","volume":"54","author":"Yang","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0235","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/s41598-021-84938-8","article-title":"Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of early onset Crohn's disease","volume":"11","author":"Horowitz","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0240","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-pathol-012615-044152","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"11","author":"Liu","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0245","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.chom.2008.05.001","article-title":"Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases","volume":"3","author":"Peterson","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0250","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0255","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00281-014-0454-4","article-title":"The gut microbiota and inflammatory bowel disease","volume":"37","author":"Matsuoka","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0265","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0270","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","article-title":"Mucus barrier, mucins and gut microbiota: the expected slimy partners?","volume":"69","author":"Paone","year":"2020","journal-title":"Gut."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0275","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1038\/ajg.2010.281","article-title":"Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria","volume":"105","author":"Png","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0280","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.gastro.2014.08.044","article-title":"Development of drugs to target interactions between leukocytes and endothelial cells and treatment algorithms for inflammatory bowel diseases","volume":"147","author":"Danese","year":"2014","journal-title":"Gastroenterology."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0285","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2174\/13894501113146660206","article-title":"Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells","volume":"14","author":"Jovani","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0290","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"OCTAVE induction 1, OCTAVE induction 2, and OCTAVE sustain investigators, tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0295","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0300","first-page":"811","article-title":"Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation, digestive and liver disease","volume":"37","author":"Danese","year":"2005"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0305","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0022-3565(24)35212-7","article-title":"Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms","volume":"291","author":"Banan","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0310","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0006-2952(98)00333-5","article-title":"Inhibition of oxidant-induced barrier disruption and protein tyrosine phosphorylation in Caco-2 cell monolayers by epidermal growth factor","volume":"57","author":"Rao","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0315","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0320","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1222669110","article-title":"Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0325","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3109\/10715762.2013.832239","article-title":"Chemistry meets biology in colitis-associated carcinogenesis","volume":"47","author":"Mangerich","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0330","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0891-5849(92)90079-V","article-title":"Oxygen radicals in ulcerative colitis","volume":"13","author":"Babbs","year":"1992","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0335","doi-asserted-by":"crossref","first-page":"4535194","DOI":"10.1155\/2017\/4535194","article-title":"Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies","volume":"2017","author":"Tian","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0340","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1128\/IAI.00530-12","article-title":"Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB\/c Rag2\u2212\/\u2212 mouse model of inflammatory bowel disease","volume":"80","author":"Muthupalani","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0345","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/MIB.0000000000000174","article-title":"Immuno-genomic profiling of patients with inflammatory bowel disease: a systematic review of genetic and functional in vivo studies of implicated genes","volume":"20","author":"Coelho","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0350","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.157.3.1261","article-title":"Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5","volume":"157","author":"Fuss","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0355","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2011.08.006","article-title":"Metabolome and inflammasome in inflammatory bowel disease","volume":"160","author":"Nanau","year":"2012","journal-title":"Transl. Res."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0365","doi-asserted-by":"crossref","first-page":"8813558","DOI":"10.1155\/2020\/8813558","article-title":"The function and role of the Th17\/Treg cell balance in inflammatory bowel disease","volume":"2020","author":"Yan","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0370","doi-asserted-by":"crossref","first-page":"741934","DOI":"10.3389\/fimmu.2021.741934","article-title":"Stigmasterol restores the balance of Treg\/Th17 cells by activating the butyrate-PPAR\u03b3 axis in colitis","volume":"12","author":"Wen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0375","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0380","doi-asserted-by":"crossref","first-page":"832","DOI":"10.14309\/ajg.0000000000000608","article-title":"Effect of lifestyle factors on outcomes in patients with inflammatory bowel diseases","volume":"115","author":"Rozich","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0385","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2011.44","article-title":"Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature","volume":"106","author":"Hou","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0390","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5507\/bp.2016.052","article-title":"Nutrition, oxidative stress and intestinal dysbiosis: influence of diet on gut microbiota in inflammatory bowel diseases","volume":"160","author":"Tomasello","year":"2016","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0395","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/gutjnl-2013-305304","article-title":"Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease","volume":"63","author":"Ananthakrishnan","year":"2014","journal-title":"Gut."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0400","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.07.050","article-title":"A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis","volume":"145","author":"Ananthakrishnan","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0405","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/nu3100858","article-title":"Regulation of inflammation by short chain fatty acids","volume":"3","author":"Vinolo","year":"2011","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0410","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/00365521.2014.966753","article-title":"Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease","volume":"50","author":"Kvasnovsky","year":"2015","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0415","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ibd.21805","article-title":"Cesarean section and offspring's risk of inflammatory bowel disease: a national cohort study","volume":"18","author":"Bager","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0420","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02236893","article-title":"High incidence of inflammatory bowel disease in the netherlands: results of a prospective study. The South Limburg IBD Study Group","volume":"41","author":"Russel","year":"1998","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0425","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000442929","article-title":"Psychological stress and depression: risk factors for IBD?","volume":"34","author":"Bernstein","year":"2016","journal-title":"Dig. Dis."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0430","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2174\/1389450115666140627151702","article-title":"State of the art: psychotherapeutic interventions targeting the psychological factors involved in IBD","volume":"15","author":"Leone","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0435","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1097\/MIB.0000000000000543","article-title":"Mesenchymal stem cell therapy for inflammatory bowel disease: a systematic review and meta-analysis","volume":"21","author":"Dave","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0440","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1007\/s12325-019-01101-6","article-title":"Subcutaneous injection of drugs: literature review of factors influencing pain sensation at the injection site","volume":"36","author":"Usach","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0445","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s13023-022-02511-6","article-title":"Rapamycin nanoparticles improves drug bioavailability in PLAM treatment by interstitial injection","volume":"17","author":"Shi","year":"2022","journal-title":"Orphanet J. Rare. Dis."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0450","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/jvp.13086","article-title":"Pharmacokinetics and bioavailability of danofloxacin in swan geese (Anser cygnoides) following intravenous, intramuscular, subcutaneous, and oral administrations","volume":"45","author":"Durna Corum","year":"2022","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0455","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13045-022-01328-x","article-title":"Targeting macrophages in hematological malignancies: recent advances and future directions","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0460","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jconrel.2015.07.019","article-title":"Cell membrane-camouflaged nanoparticles for drug delivery","volume":"220","author":"Luk","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0470","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.7150\/thno.36510","article-title":"Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery","volume":"9","author":"Sun","year":"2019","journal-title":"Theranostics."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0475","doi-asserted-by":"crossref","first-page":"100228","DOI":"10.1016\/j.mtbio.2022.100228","article-title":"Cell membrane camouflaged biomimetic nanoparticles: focusing on tumor theranostics","volume":"14","author":"Zhu","year":"2022","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0480","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0485","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0490","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2021.08.021","article-title":"Biomimetic cell membrane-coated DNA nanoparticles for gene delivery to glioblastoma","volume":"338","author":"Han","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0495","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1517\/14656560902973728","article-title":"Treatment of steroid-naive ulcerative colitis","volume":"10","author":"Bossa","year":"2009","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0500","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1572-0241.2005.41412.x","article-title":"Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients-a pilot uncontrolled study","volume":"100","author":"Annese","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0505","article-title":"Erythrocytes-mediated delivery of dexamethasone 21-phosphate in steroid-dependent ulcerative colitis: a randomized, double-blind sham-controlled study","volume":"1","author":"Bossa","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0510","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/j.1572-0241.2008.02103.x","article-title":"Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study","volume":"103","author":"Bossa","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0515","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2217\/nnm-2017-0100","article-title":"Cell membrane-derived nanoparticles: emerging clinical opportunities for targeted drug delivery","volume":"12","author":"Yurkin","year":"2017","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0520","doi-asserted-by":"crossref","first-page":"1083007","DOI":"10.3389\/fmicb.2023.1083007","article-title":"Recent advances of cell membrane-coated nanoparticles for therapy of bacterial infection","volume":"14","author":"Song","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.apsb.2017.12.002","article-title":"Biomimetic nanoparticles for inflammation targeting","volume":"8","author":"Jin","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0530","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s40820-019-0330-9","article-title":"Cell membrane coating technology: a promising strategy for biomedical applications","volume":"11","author":"Liu","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0535","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/acsami.1c19388","article-title":"Visualization of acute inflammation through a macrophage-camouflaged afterglow nanocomplex","volume":"14","author":"Wang","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0540","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jconrel.2021.07.032","article-title":"Macrophage-biomimetic anti-inflammatory liposomes for homing and treating of aortic dissection","volume":"337","author":"Liu","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.07.011","article-title":"Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain","volume":"142","author":"Yuan","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0550","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.7150\/thno.48448","article-title":"Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0555","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1021\/acsami.1c21700","article-title":"Biomimetic MOF nanoparticles delivery of C-dot nanozyme and CRISPR\/Cas 9 system for site-specific treatment of ulcerative colitis","volume":"14","author":"Ma","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0560","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202200289","article-title":"Macrophage cell membrane-cloaked nanoplatforms for biomedical applications","volume":"6","author":"Lopes","year":"2022","journal-title":"Small Methods"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0565","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbi.2020.12.026","article-title":"Platelet endothelial cell adhesion molecule-1 is a gatekeeper of neutrophil transendothelial migration in ischemic stroke","volume":"93","author":"Winneberger","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0570","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/ejh.12178","article-title":"Role of the adhesion molecule CD99 in platelet-neutrophil interactions","volume":"91","author":"Pliyev","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0575","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-5728(93)90275-4","article-title":"Circulating intercellular adhesion molecule-1 levels and neutrophil adhesion in stroke","volume":"44","author":"Clark","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0580","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1021\/acsnano.0c07973","article-title":"Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery","volume":"15","author":"Feng","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0585","article-title":"Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke","volume":"13","author":"X","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0590","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706245","article-title":"Neutrophil-based drug delivery systems","volume":"30","author":"Chu","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0595","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1038\/s41467-021-26052-x","article-title":"Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0600","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/1061186021000001878","article-title":"Accumulation of PEG-liposomes in the inflamed colon of rats: potential for therapeutic and diagnostic targeting of inflammatory bowel diseases","volume":"10","author":"Awasthi","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0605","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2019.02.034","article-title":"Ulcerative colitis-specific delivery of keratinocyte growth factor by neutrophils-simulated liposomes facilitates the morphologic and functional recovery of the damaged colon through alleviating the inflammation","volume":"299","author":"Zhao","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0610","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706245","article-title":"Neutrophil-based drug delivery systems","volume":"30","author":"Chu","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0615","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00441-017-2776-8","article-title":"Neutrophil chemotaxis","volume":"371","author":"Petri","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0620","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000442925","article-title":"Endothelial cell-immune cell interaction in IBD","volume":"34","author":"Danese","year":"2016","journal-title":"Dig. Dis."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0625","doi-asserted-by":"crossref","first-page":"14581","DOI":"10.1039\/C7NR04734G","article-title":"Engineered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases","volume":"9","author":"Corbo","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0630","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-14-3095","article-title":"Grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites","volume":"75","author":"Wang","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0635","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0640","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/mol.119.116954","article-title":"Antibodies targeting chemokine receptors CXCR4 and ACKR3","volume":"96","author":"Bobkov","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0645","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1039\/D0FO02786C","volume":"12","author":"Liu","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0650","doi-asserted-by":"crossref","first-page":"9416794","DOI":"10.1155\/2021\/9416794","article-title":"The preventive effect of lactobacillus plantarum ZS62 on DSS-induced IBD by regulating oxidative stress and the immune response","volume":"2021","author":"Pan","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0655","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4014\/jmb.2003.03041","article-title":"Physiological characteristics of lactobacillus casei strains and their alleviation effects against inflammatory bowel disease","volume":"31","author":"Liu","year":"2021","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0660","doi-asserted-by":"crossref","first-page":"8030297","DOI":"10.1155\/2021\/8030297","article-title":"Bifidobacterium Longum: protection against inflammatory bowel disease","volume":"2021","author":"Yao","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0665","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1039\/D2FO00226D","article-title":"Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications","volume":"13","author":"Zhao","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0670","doi-asserted-by":"crossref","first-page":"100543","DOI":"10.1016\/j.mtbio.2023.100543","article-title":"Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies","volume":"18","author":"Chen","year":"2023","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0675","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1007\/s00253-021-11453-1","article-title":"The potential of Akkermansia muciniphila in inflammatory bowel disease","volume":"105","author":"Zhang","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0680","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3389\/fmicb.2019.02259","article-title":"Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice","volume":"10","author":"Bian","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0685","first-page":"1594","volume":"12","author":"Cunningham","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0690","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1038\/s41467-019-11390-8","article-title":"Camouflaging bacteria by wrapping with cell membranes","volume":"10","author":"Cao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0695","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17425247.2019.1551874","article-title":"Yeast-inspired drug delivery: biotechnology meets bioengineering and synthetic biology","volume":"16","author":"Sabu","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0700","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2217\/fmb.15.69","article-title":"Bacterial resistance in biofilm-associated bacteria","volume":"10","author":"Venkatesan","year":"2015","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2018.10.005","article-title":"Physico-chemistry from initial bacterial adhesion to surface-programmed biofilm growth","volume":"261","author":"Carniello","year":"2018","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0710","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.mib.2013.06.013","article-title":"Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies","volume":"16","author":"de la Fuente-N\u00fa\u00f1ez","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0715","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jfda.2018.12.011","article-title":"Next generation probiotics in disease amelioration","volume":"27","author":"Chang","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0720","doi-asserted-by":"crossref","first-page":"106146","DOI":"10.1016\/j.phrs.2022.106146","article-title":"Emerging pharmacotherapy for inflammatory bowel diseases","volume":"178","author":"Luo","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0725","article-title":"Bioinspired oral delivery of gut microbiota by self-coating with biofilms","volume":"6","author":"Wang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0730","doi-asserted-by":"crossref","first-page":"102575","DOI":"10.1016\/j.nano.2022.102575","article-title":"Vesicles of yeast cell wall-sitagliptin to alleviate neuroinflammation in Alzheimer's disease","volume":"44","author":"Mozafari","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0735","doi-asserted-by":"crossref","first-page":"118612","DOI":"10.1016\/j.carbpol.2021.118612","article-title":"\u03b2-1,3-d-glucan based yeast cell wall system loaded emodin with dual-targeting layers for ulcerative colitis treatment","volume":"273","author":"Pu","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0740","doi-asserted-by":"crossref","first-page":"120583","DOI":"10.1016\/j.ijpharm.2021.120583","article-title":"Utilization of PLGA nanoparticles in yeast cell wall particle system for oral targeted delivery of exenatide to improve its hypoglycemic efficacy","volume":"601","author":"Ren","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0745","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1021\/acs.biomac.1c00425","article-title":"Entrapment of macrophage-target nanoparticles by yeast microparticles for Rhein delivery in ulcerative colitis treatment","volume":"22","author":"Chen","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0750","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.apsb.2020.12.022","article-title":"An update on oral drug delivery via intestinal lymphatic transport","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0755","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1139\/bcb-2020-0121","article-title":"Comparative effect of bovine buttermilk, whey, and lactoferrin on the innate immunity receptors and oxidative status of intestinal epithelial cells","volume":"99","author":"Buey","year":"2021","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0760","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11483-018-9546-3","article-title":"Yeast cell microcapsules as a novel carrier for cholecalciferol encapsulation: development, characterization and release properties","volume":"13","author":"Dadkhodazade","year":"2018","journal-title":"Food Biophys."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0765","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf0677","article-title":"Mucosal immunity-mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer's patches","volume":"7","author":"Lin","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0770","doi-asserted-by":"crossref","first-page":"32901","DOI":"10.1021\/acsami.2c06981","article-title":"Polydopamine-based nanocomposite as a biomimetic antioxidant with a variety of enzymatic activities for parkinson's disease","volume":"14","author":"Wang","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0775","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s10570-020-03596-7","article-title":"Mussel-inspired biocompatible polydopamine\/carboxymethyl cellulose\/polyacrylic acid adhesive hydrogels with UV-shielding capacity","volume":"28","author":"Tang","year":"2021","journal-title":"Cellulose"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0780","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1039\/D0BM01070G","article-title":"Polydopamine free radical scavengers","volume":"8","author":"Hu","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0785","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.actbio.2023.02.026","article-title":"ROS scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease","volume":"161","author":"Bao","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0790","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000519363","article-title":"Targeting pathophysiological changes using biomaterials-based drug delivery systems: a key to managing inflammatory bowel disease","volume":"14","author":"Li","year":"2022","journal-title":"J. Innate. Immun."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0795","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.actbio.2023.02.026","article-title":"Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease","volume":"161","author":"ROS","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0800","doi-asserted-by":"crossref","first-page":"1045575","DOI":"10.3389\/fphar.2022.1045575","article-title":"Targeting pathophysiological changes using biomaterials-based drug delivery systems: a key to managing inflammatory bowel disease","volume":"13","author":"Mohajeri","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0805","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0810","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrd4333","article-title":"Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery","volume":"13","author":"Torchilin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0815","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/ecco-jcc\/jjy181","article-title":"A molecular targeted immunotherapeutic strategy for ulcerative colitis via dual-targeting nanoparticles delivering miR-146b to intestinal macrophages","volume":"13","author":"Deng","year":"2019","journal-title":"J. Crohn's Colitis"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0820","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijbiomac.2020.12.094","article-title":"Macrophages-targeting mannosylated nanoparticles based on inulin for the treatment of inflammatory bowel disease (IBD)","volume":"169","author":"Sun","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0825","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1021\/nn502861t","article-title":"Bimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles","volume":"8","author":"Dreaden","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0830","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ymthe.2016.11.020","article-title":"Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis","volume":"25","author":"Xiao","year":"2017","journal-title":"Mol. Therapy"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0835","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejps.2018.10.009","article-title":"Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-\u03b1 siRNA provide a novel strategy for the experimental treatment of ulcerative colitis","volume":"125","author":"Huang","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0840","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2014.01.056","article-title":"Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice","volume":"146","author":"Xiao","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0845","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1039\/C9BM00925F","article-title":"A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine a to alleviate acute severe ulcerative colitis","volume":"7","author":"Wu","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0850","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.biomaterials.2012.10.003","article-title":"Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug delivery","volume":"34","author":"Du","year":"2013","journal-title":"Biomaterials."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0855","doi-asserted-by":"crossref","first-page":"113887","DOI":"10.1016\/j.addr.2021.113887","article-title":"Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases","volume":"176","author":"Zu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0860","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2014.04.046","article-title":"Fab\u2032-bearing siRNA TNF\u03b1-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis","volume":"186","author":"Laroui","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0865","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2012.06.007","article-title":"Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1","volume":"163","author":"Ghaffarian","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0870","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0142-9612(01)00349-0","article-title":"Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes","volume":"23","author":"Eniola","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0875","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nmat2859","article-title":"Orally delivered thioketal nanoparticles loaded with TNF-\u03b1\u2013siRNA target inflammation and inhibit gene expression in the intestines","volume":"9","author":"Wilson","year":"2010","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0880","article-title":"Rutin-loaded stimuli-responsive hydrogel for anti-inflammation","author":"Wang","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0885","doi-asserted-by":"crossref","first-page":"644387","DOI":"10.3389\/fphar.2021.644387","article-title":"Berberine-loaded carboxylmethyl chitosan nanoparticles ameliorate DSS-induced colitis and remodel gut microbiota in mice","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0890","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acs.molpharmaceut.0c01245","article-title":"Smart responsive quercetin-conjugated glycol chitosan prodrug micelles for treatment of inflammatory bowel diseases","volume":"18","author":"Shen","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0895","doi-asserted-by":"crossref","first-page":"119252","DOI":"10.1016\/j.carbpol.2022.119252","article-title":"Hydrogen peroxide responsive covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease","volume":"285","author":"Huang","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0900","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000973","article-title":"Mesopore to macropore transformation of metal-organic framework for drug delivery in inflammatory bowel disease","volume":"10","author":"Yin","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0905","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1021\/mp9000926","article-title":"Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa","volume":"6","author":"Tirosh","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0910","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1572-0241.2002.05837.x","article-title":"A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease","volume":"97","author":"Peterson","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0915","doi-asserted-by":"crossref","first-page":"121364","DOI":"10.1016\/j.biomaterials.2022.121364","article-title":"Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease","volume":"281","author":"Kotla","year":"2022","journal-title":"Biomaterials."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0920","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.actbio.2022.03.012","article-title":"Genetically engineered pH-responsive silk sericin nanospheres with efficient therapeutic effect on ulcerative colitis","volume":"144","author":"Xu","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0925","doi-asserted-by":"crossref","first-page":"119533","DOI":"10.1016\/j.ijpharm.2020.119533","article-title":"Ascorbyl-dipalmitate-stabilised nanoemulsions as a potential localised treatment of inflammatory bowel diseases","volume":"586","author":"Plaza-Oliver","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0930","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.biomaterials.2018.09.024","article-title":"Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine","volume":"185","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0935","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2014.07.009","article-title":"pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease","volume":"473","author":"Beloqui","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0940","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.carbpol.2018.06.107","article-title":"Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan\/alginate\/Eudragit S multilayers for the treatment of inflammatory bowel disease","volume":"198","author":"Oshi","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0945","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2015.02.044","article-title":"Formulation and characterization of ORMOSIL particles loaded with budesonide for local colonic delivery","volume":"484","author":"Petrovska-Jovanovska","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0950","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jconrel.2019.10.054","article-title":"A self-assembled, ROS-responsive janus-prodrug for targeted therapy of inflammatory bowel disease","volume":"316","author":"Li","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0955","article-title":"White blood cell membrane-coated nanoparticles: recent development and medical applications","volume":"11","author":"Wang","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0960","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202006484","article-title":"Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy","volume":"17","author":"Oroojalian","year":"2021","journal-title":"Small."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0965","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606209","article-title":"Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization","volume":"29","author":"Dehaini","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0970","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2018.06.021","article-title":"Bioresponsive drug delivery systems in intestinal inflammation: state-of-the-art and future perspectives","volume":"146","author":"Kotla","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0975","first-page":"7207268","article-title":"Protective role of coxsackie-adenovirus receptor in the pathogenesis of inflammatory bowel diseases","volume":"2018","author":"Chen","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0980","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/1873-3468.13794","article-title":"The coxsackievirus and adenovirus receptor: virological and biological beauty","volume":"594","author":"Excoffon","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0985","first-page":"145","article-title":"Effectiveness and safety of COVID-19 vaccines in patients with inflammatory bowel disease","volume":"18","author":"Spiera","year":"2022","journal-title":"Gastroenterol. Hepatol. (N Y)."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0990","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","article-title":"Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb0995","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40200-020-00511-6","article-title":"Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV","volume":"19","author":"Behrouzi","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb1000","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1167\/iovs.13-12044","article-title":"In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases","volume":"54","author":"Stein","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb1005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/bioengineering9090433","article-title":"Construction and in vitro evaluation of a tumor acidic pH-targeting drug delivery system based on Escherichia coli Nissle 1917 bacterial ghosts","volume":"9","author":"Ma","year":"2022","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb1010","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.vaccine.2013.05.013","article-title":"Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection","volume":"31","author":"Garcia-Angulo","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2023.126000_bb1015","article-title":"Spontaneously right-side-out-orientated coupling-driven ROS-sensitive nanoparticles on cell membrane inner leaflet for efficient renovation in vascular endothelial injury","volume":"10","author":"Qin","year":"2023","journal-title":"Adv. Sci (Weinh)."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb1020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCRESAHA.119.315185","article-title":"B. Rapamycin-loaded biomimetic nanoparticles reverse vascular inflammation","volume":"126","author":"Boada","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb1025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41580-021-00413-2","article-title":"The mechanisms of integral membrane protein biogenesis","volume":"23","author":"Hegde","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb1030","doi-asserted-by":"crossref","first-page":"114097","DOI":"10.1016\/j.addr.2021.114097","article-title":"Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers","volume":"182","author":"Haddadzadegan","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2023.126000_bb1035","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1039\/D2NR04968F","article-title":"Programmed pH-responsive core\u2013shell nanoparticles for precisely targeted therapy of ulcerative colitis","volume":"15","author":"Zhang","year":"2023","journal-title":"Nanoscale"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023028957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023028957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:35:35Z","timestamp":1786768535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023028957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":207,"alternative-id":["S0141813023028957"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126000","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell membrane nanomaterials composed of phospholipids and glycoproteins for drug delivery in inflammatory bowel disease: A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"126000"}}